Refresh #13 in Vienna 🇦🇹- The Future of Biotech @BIO-Europe Spring

Refresh Meetup
Refresh Meetup
Public group
Location image of event venue


It's almost time for BIO-Europe Spring 😃, one of the most anticipated events on the biotech calendar! This year we get to organize our free Refresh event right at the conference! So you're invited to join us and the rest of the BIO-Europe Spring gang for a relaxed biotech meetup on the 27th March 2019 in Vienna. You'll get a free pass to BIO-Europe Spring for the rest of Wednesday! This means free entry for the closing ceremony and all other events taking place on Wednesday 27th after Refresh. What a deal.

Because this will be a pretty popular event, we will do a first come, first served, make sure to sign-up right here

➡️➡️➡️ ⬅️⬅️⬅️

📓The program 📓:

14:00– 14:45: The 5 most important upcoming trends in European biotech📈
▸Philip Hemme, CEO,
▸Werner Lanthaler, CEO, Evotec

14:50-16:35: What's lying ahead for European biotech in 2019 and beyond
▸Helen Albert, Editor-in-Chief,
▸Erich Tauber, CEO, Themis Bioscience
▸Vanessa King, CEO, Virion Biotherapeutics
▸Alexander Belcredi, CEO, PhagoMed

16:00: BIO-Europe Spring closing reception

➡️➡️➡️ ⬅️⬅️⬅️

📘Who will be speaking? 📘

📌The 5 most important upcoming trends in European biotech📌

The CEO of Evotec will discuss his views on the upcoming trends and challenges facing European biotech in the next few years.

►Werner Lanthaler◀︎ has been the CEO of Evotec since March 2009. He has done an amazing job at growing the company and transforming it into an innovation-driven company. We selected Werner to give the keynote as he is one of the best biotech leaders in Europe and as he has always been able to look ahead to predict what will come next.

📌What's lying ahead for European biotech in 2019 and beyond📌

Helen, our Editor-in-Chief, will discuss the more immediate future of European biotech and what the hot topics in 2019 and beyond will be with a panel of three great speakers from both the scientific and the investment side of the industry.

►Alexander Belcredi◀︎ spent nine years at the Boston Consulting Group where he was part of the global health care team, focusing on pharma and medtech. In 2017, he co-founded PhagoMed Biopharma GmbH, a biotech company developing phage-based pharmaceuticals to treat bacterial infections, where he is now the CEO.

►Erich Tauber◀︎ co-founded the Austrian biotech Themis Bioscience in 2009 and has been its CEO since it began. Themis focuses on developing innovative vaccines for infectious diseases such as Chikungunya and is set to move into the oncolytic vaccine space. Erice is very well placed to tell us more about new and future trends in European biotech.

►Vanessa King◀︎ has a broad experience of the biotech industry including previously heading up Luc Therapeutics, a company focused on modulating the brain’s synaptic plasticity. Vanessa is currently CEO of Virion Biotherapeutics, a UK biotech developing a first-in-class RNA immunomodulatory agent to target respiratory viruses. She is also experienced in biotech investment and is a Venture Partner at Abingworth.

To request a spot, subscribe to our Meetup page and fill the form bellow.
➡️➡️➡️ ⬅️⬅️⬅️

Thanks to EBD Group for being such a cool partner 😉

Laura & the Labiotech Team

P.S. If you have any questions or suggestions, please feel free to reach out to me at